Q2 FY2026 · ended Jun 30, 2026 · Revenue $264.16M, +4.6% YoY · Filed Aug 13, 2026
Lumexa Imaging Holdings, Inc. (LMRI) files with the SEC under industry code 8071, Services-Medical Laboratories. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $264.2 million and net income of $2.7 million. Free cash flow was $23.1 million. As of Jun 30, 2026 it held $69.7 million in cash and investments and $975.4 million in total debt.
Revenue
$264.16M
+4.6% vs prior quarter
Net income
$2.75M
+59.9% vs prior quarter
Operating cash flow
$32.80M
+1018.7% vs prior quarter
Free cash flow
$23.13M
+1071.0% vs prior quarter
EPS
$0.03
+50.0% vs prior quarter
Dividend per share
None
Shares outstanding
96.07M
-0.0% vs prior quarter
Net cash
$-905.65M
Q2 FY2026
Operating margin
8.7%
Q2 FY2026
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- LMRI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Raleigh, NC
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2071288
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
|---|---|---|
| Revenue | $264.2M | $252.5M |
| Operating income | $23.0M | $19.4M |
| Net income | $2.7M | $1.7M |
| Diluted EPS | $0.03 | $0.02 |
| Operating cash flow | $32.8M | $2.9M |
| Free cash flow | $23.1M | -$2.4M |
| Total assets | $1.8B | $1.8B |
| Total liabilities | $1.2B | $1.2B |
| Stockholders' equity | $615.1M | $599.6M |
| Cash and investments | $69.7M | $51.2M |
| Total debt | $975.4M | $967.5M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 10, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 12, 2026 | May 12, 2026 |
All 71 Lumexa Imaging Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.